Serum levels of chemokines IP-10, IL-8 and SDF-1 serve as good biomarkers for diabetes-tuberculosis nexus.
Inflammation has long been identified as an essential component of both Type-2 diabetes and tuberculosis. Chemokines are low molecular weight proteins which play an important role in both inflammation (diabetes) and immunity (tuberculosis). In this study, we measured the serum levels of IP-10, IL-8 and SDF-1 in subjects with Normal Glucose Tolerance (NGT-TB- = 108; NGT-TB+ = 200), Pre-Diabetes (PDM-TB- = 118; PDM-TB+ = 105), Newly Diagnosed Diabetes (NDM-TB- = 105; NDM-TB+ = 63) and Known Diabetes (KDM-TB- = 131; KDM-TB+ = 108), by ELISA. Along with chemokines pro-inflammatory cytokines TNF-ɑ and IL-6 were also measured in these groups. While IP-10 levels were significantly reduced in TB+ subjects in all the sub-groups, IL-8 levels were significantly reduced in NDM-TB+ and increased in KDM-TB+ subjects. SDF-1 levels were significantly elevated in TB+ subjects in all the subgroups, except for KDM-TB+. Altered serum chemokine levels can alter anti-TB immunity in diabetes patients and can fuel DM-TB nexus.